β3 Agonists Do Not Cut Dementia Risk Versus Anticholinergics in OAB
TUESDAY, Nov. 17, 2026-- β3 agonists are not associated with a lower dementia incidence compared with anticholinergics among patients initiating treatment for overactive bladder (OAB), according to a study published online Nov. 6 in JAMA Network...